微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | -0.62% | 36.73% | 88.41% | 116/159 | -0.37% | 翰宇药业 | 11.39% | 行业排名> |
| 2024-12-31 | -5.35% | -10.77% | -205.71% | 113/159 | -9.52% | 百利天恒 | 181.27% | 行业排名> |
| 2024-09-30 | -1.75% | 54.19% | 23.58% | 122/159 | 4.18% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | -2.29% | 20.21% | -133.67% | 126/159 | 2.63% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | -0.98% | -34.25% | 79.71% | 124/159 | 2.32% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | -4.83% | 9.55% | -26.44% | 118/159 | -1.03% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | -3.82% | -36.92% | -33.1% | 126/159 | 2.35% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | -2.87% | -7.89% | -293.15% | 125/159 | 1.47% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | -0.73% | -4.29% | 86.33% | 125/159 | 1.38% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | -5.34% | 4.64% | -91.4% | 120/159 | 0.74% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | -2.79% | 5.1% | -4.89% | 120/159 | 2.89% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | -2.66% | -13.19% | -280% | 127/159 | 2.22% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | -0.7% | 35.78% | 87.5% | 119/159 | 1.61% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | -5.6% | -0.36% | -90.48% | 123/159 | 0.87% | 人福医药 | 6.82% | 行业排名> |
| 2021-09-30 | -2.94% | 31.15% | -25.11% | 122/159 | 4.53% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | -2.35% | 7.48% | -115.6% | 125/159 | 2.99% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | -1.09% | -303.7% | 80.47% | 116/159 | 2.52% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | -5.58% | 33.65% | -30.68% | 117/159 | 3.71% | 哈三联 | 27.17% | 行业排名> |
| 2020-09-30 | -4.27% | -93.21% | -68.11% | 106/159 | 3.22% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-06-30 | -2.54% | -1594.12% | -840.74% | 115/159 | 4.24% | 河化股份 | 45.32% | 行业排名> |
| 2020-03-31 | -0.27% | -177.14% | 96.79% | 90/159 | 2.24% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-12-31 | -8.41% | -351.8% | -280.54% | 124/159 | 2.71% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-09-30 | -2.21% | -148.57% | -1400% | 102/159 | 7.61% | 奥赛康 | 35% | 行业排名> |
| 2019-06-30 | 0.17% | -94.08% | -51.43% | 105/159 | 5.02% | 奥赛康 | 28.15% | 行业排名> |
| 2019-03-31 | 0.35% | -83.25% | -89.52% | 97/159 | 2.46% | 宏源药业 | 21.91% | 行业排名> |
| 2018-12-31 | 3.34% | -62.81% | -26.59% | 103/159 | 7.09% | 奥赛康 | 9.7% | 行业排名> |
| 2018-09-30 | 4.55% | -32.49% | 58.54% | 74/159 | 7.26% | 奥赛康 | 40.69% | 行业排名> |
| 2018-06-30 | 2.87% | -37.06% | 37.32% | 70/159 | 4.65% | 信立泰 | 25.93% | 行业排名> |
| 2018-03-31 | 2.09% | 2% | -76.73% | 53/159 | 2.55% | 昂利康 | 15.91% | 行业排名> |
| 2017-12-31 | 8.98% | -26.33% | 33.23% | 58/159 | 9.66% | 奥赛康 | 12.08% | 行业排名> |
| 2017-09-30 | 6.74% | 2% | 47.81% | 50/159 | 8.31% | 一品红 | 31.62% | 行业排名> |
| 2017-06-30 | 4.56% | 2% | -62.59% | 51/159 | 5.59% | 丽珠集团 | 49.43% | 行业排名> |
| 2016-12-31 | 12.19% | 9.72% | 9.72% | 43/159 | 6.33% | 河化股份 | 54.24% | 行业排名> |
| 2015-12-31 | 11.11% | -13.61% | -13.61% | 46/159 | 11.35% | 华东医药 | 7.2% | 行业排名> |